The authors describe a case in which flupenthixol decanoate and imipramine were co-administered to a patient with schizophrenia, resulting in extremely high levels of imipramine and its metabolite, desipramine. The literature on the co-administration of neuroleptics and antidepressants is reviewed and guidelines for limiting possible iatrogenic effects of the combination are suggested.
References
1.
MoodyJ.P., TaitA.C., TodrickA.Plasma levels of imipramine and desmethylimipramine during therapy.Br J Psychiatry1967; 113: 183–193.
2.
VandelB., VandelS., AllersG.Interaction between amitriptyline and phenothiazine in man: effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response.Psychopharmacology (Berlin)1979; 65: 187–190.
Kragh-SorensonP., BorgaG., CarleL.Effect of simultaneous treatment with low doses of perphenazine on plasma and urine concentrations of nortriptyline and 10-hydroxynortriptyline.Eur J Clin Pharmacol1977; 11: 479–483.
GarveyM.J., TuasonV.B., JohnsonR.A.Elevated plasma tricyclic levels with therapeutic doses of imipramine.Am J Psychiatry1984; 141: 853–856.
11.
PreskornS., IrwinH.A.Toxicity of antidepressants: kinetics, mechanism, intervention: a review.J Clin Psychiatry1982; 43: 151–156.
12.
ShalevA., RatzoniG., MunitzH.Rate of change in tricyclic plasma levels important. Letters to the editor.Am J Psychiatry1985; 142: 3: 388–389.
13.
LinnoilaM., GeorgeL., GuthrieS.Interaction between antidepressants and perphenazine in psychiatric inpatients.Am J Psychiatry1982; 139: 1329–1331.
14.
NelsonJ.C., JatlowP.I., BockJ.Major adverse reactions during desipramine treatment: relationship to plasma drug concentrations, concomitant antipsychotic treatment, and patient characteristics.Arch Gen Psychiatry1982; 39: 1055–1061.
15.
BockJ.L., NelsonJ.C., GrayS.Desipramine hydroxylation: variability and effect of antipsychotic drugs.Clin Pharmacol Ther1983; 33: 322–328.
16.
BurrowsG.D., VohraJ., DumovicP.Tricyclic antidepressant drugs in cardiac conduction.Progress in neuropharmacology1977; 1: 329–334.
17.
SiggE.G., OsborneM., PorolB.Cardiovascular Effects of imipramine.J Pharmacol and Exper Ther1963; 141: 237–243.
18.
FlemingL.P.Personal communication.Bristol Laboratories of Canada,1984.
19.
More problems with trazodone (Desyrel).Massachusetts General Hospital Newsletter: Biological Therapies in Psychiatry1984; 7(1): 2.
